In ccRCC, the PBRM1 gene is often co-mutated with SETD2 (Varela et al., 2011), and some studies have predicted that SETD2 mutations are associated with poor prognosis in primary ccRCC (Piva et al., 2015). Here, SETD2 is linked to nonpapillary renal cell carcinoma.